Latest

Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease

Wednesday, 20 May 2026 10:04AM

SHANGHAI, May 20 (Bernama-GLOBE NEWSWIRE) -- Risen Pharma, a clinical-stage biotech company focusing...

See More
Hack The Box Report Reveals AI-Driven Shift Reshaping Cybersecurity Skills and Talent Strategy

Wednesday, 20 May 2026 9:43AM

New global data shows AI is changing cybersecurity roles, accelerating demand for advanced capabilit...

See More

Other Press Release

MREM Banner
MREM Banner

Another project by BERNAMA Media Relations and Event Management (MREM)

Click here to add free PRESS RELEASES to your website